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doi:10.1016/j.jtcvs.2006.09.045bjective: There is no common guideline on what temperature should be achieved
t the lower body circulatory arrest followed by the initiation of selective cerebral
erfusion.
ethods: Between October 1999 and August 2005, a total of 377 patients underwent
epair of the aortic arch with selective cerebral perfusion and hypothermic circula-
ory arrest at 20°C to 28°C and were divided into two groups: (1) 125 patients with
eep lower body circulatory arrest at 20°C to 24.9°C (deep lower body circulatory
rrest group) and (2) 252 patients with moderate lower body circulatory arrest at
5°C to 28°C (moderate lower body circulatory arrest group). To compensate for the
ifferences in patient characteristics, we used a propensity score matching analysis,
nd comparable patients, 92 patients from each group, were identified for final
nalysis.
esults: There were no significant differences in mortality or morbidity between
eep and moderate lower body circulatory arrest, in either the entire study cohort or
he propensity-matched cohort. C-reactive protein level 1 day after the operation
pproached but fell short of significance (108.4  47.7 mg/L in deep lower body
irculatory arrest group and 95.8  44.2 mg/L in moderate lower body circulatory
rrest group, P  .07). The mean temperatures at the initiation of lower body
irculatory arrest were 24.1°C  2.2°C in patients who underwent reexploration for
leeding and 24.9°C 1.8°C in patients who did not (P .025); the difference also
eached statistical significance in multivariate analysis (P  .046, odds ratio 0.796).
onclusions: Our results suggest that moderate lower body circulatory arrest can be
afely performed for aortic arch repair. In fact, postoperative inflammatory response
ended to be lower in patients with moderate lower body circulatory arrest than those
ith deep lower body circulatory arrest, and deep lower body circulatory arrest was
strong risk factor for reexploration for bleeding.
lthough the introduction of deep hypothermic circulatory arrest (HCA)
improved surgical results of more extensive operations on the thoracic
aorta,1,2 these complex procedures are still associated with a relatively high
ortality and high incidences of neurologic complications. As is well known, the
afe duration of HCA alone is limited,3-6 and HCA is therefore normally performed
ith the use of retrograde cerebral perfusion or antegrade selective cerebral perfu-
ion (SCP). Because the real benefit of retrograde cerebral perfusion is not uni-
ormly accepted,6,7 the combination of HCA and SCP is currently adopted in many
nstitutions. There is no common guideline as to the temperature that should be
chieved before extracorporeal circulation can be stopped and followed by the
nitiation of SCP, however, and each institution has its own protocol.
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5
CSPUntil now, discussions regarding HCA have been fo-
used on cerebral protection and neurologic outcome. Orig-
nally, deep HCA was introduced as a method of cerebral
rotection, and because the brain is the most sensitive organ
o ischemic injury, it is considered that the temperature
hould be dropped to 20°C or lower when no other adjunct
erebral protection is available. With the use of SCP, how-
ver, HCA acts as lower body circulatory arrest (LBCA),
nd the temperature for HCA can therefore be higher. To
istinguish between HCA of the entire body and HCA of the
ower body, HCA with the use of SCP is defined as LBCA
n this article.
In recent years, the trend has gone from deep tempera-
ures, cooler than 20°C as advocated by the Mount Sinai
roup,6 toward temperatures as high as 25°C.8-10 The avoid-
nce of deep core temperatures at LBCA may offer the
dvantage of shorter cardiopulmonary bypass (CPB) times
nd reductions in coagulation disorders and the accumula-
ion of inflammatory parameters, but it can theoretically
ause ischemic injury to the visceral organs and the spinal
ord.
In our institution, SCP was introduced in 1999 in com-
ination with deep HCA at temperatures lower than 20°C.
he temperature of LBCA has gone higher as we gained
xperience, and it is now performed at 25°C to 28°C. This
emperature is clearly higher than in other institutions,
here it is performed at 20° to 25°C.8-10 It is difficult to say
hether the results are acceptable, however, because previ-
us studies had no control group regarding the temperature
f LBCA. The aim of this study was to compare the in-
ospital outcomes of patients with LBCA at 25°C to 28°C
ith those of a propensity-matched group of patients with
BCA at 20°C to 24.9°C.
atients and Methods
atients
etween October 1999 and August 2005, a total of 832 adult
atients underwent surgery for ascending aortic disease through a
edian sternotomy with or without a repair of the aortic arch, and
BCA (HCA with SCP) was used in 473 cases. Among these
atients, 60 who were operated on with the use of profound LBCA
t a nasopharyngeal temperature lower than 20°C and 36 operated
n with the use of moderate LBCA at a nasopharyngeal temper-
ture higher than 28°C were excluded; the remaining 377 patients
ere retrospectively examined in this study. These 377 patients
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
HCA  hypothermic circulatory arrest
LBCA lower body circulatory arrest
SCP  selective cerebral perfusionere divided into two groups according to nasopharyngeal tem- a
02 The Journal of Thoracic and Cardiovascular Surgery ● Febrerature at the initiation of HCA: (1) 125 patients (33.1%) under-
ent deep LBCA at a nasopharyngeal temperature of 20°C to
4.9°C (deep LBCA group) and (2) 252 patients (66.9%) under-
ent moderate LBCA at a nasopharyngeal temperature of 25°C to
8°C (moderate LBCA group). All patient characteristics were
ssessed and are presented in Table 1. The distribution of patients
ccording to HCA time is shown in Figure 1.
perative Technique
nesthesia was induced and maintained in a standard manner. The
roximal thoracic aorta was approached through a median sternot-
my in all cases. After systemic heparinization, CPB was instituted
ith a cannula for arterial return to the aortic arch, even in cases
f acute aortic dissection type A,10 and a venous single two-stage
annula in the right atrium. The left side of the heart was vented
hrough the right superior pulmonary vein. Myocardial protection
as achieved with cold blood cardioplegia. The ascending aorta
as clamped, and manipulation of the proximal site was per-
ormed. After the patient was cooled to the target temperature, the
ystemic circulation was arrested, the aneurysm was opened, and
he arterial cannula was removed. With the patient in the Tren-
elenburg position, 15F retrograde coronary sinus perfusion can-
ulas (Medtronic DLP, Grand Rapids, Mich) connected to the
xygenator with a separate single-roller pump head were inserted
nto the innominate artery and the left carotid artery. The left
ubclavian artery was clamped or occluded with a Fogarty catheter
Baxter Healthcare Corporation, Deerfield, Ill) to avoid the steal
henomenon. For SCP, cold blood at 15°C was perfused with a
ircuit for blood cardioplegia. Cerebral perfusion was initiated at a
ate of 10 ml/(min · kg) and adjusted to maintain a pressure be-
ween 40 and 60 mm Hg. After the aortic arch was repaired, SCP
as ceased and CPB was resumed with the perfusion cannula
irectly reinserted into the graft. Deairing was performed in a
tandard manner.
efinitions of Complications
n accordance with the report by Ergin and colleagues,5 we defined
emporary neurologic dysfunction as the occurrence of at least one
f the following symptoms: postoperative confusion, agitation,
elirium, prolonged obtundation, or transient parkinsonism with-
ut obvious neurologic deficit. Stroke was defined as the presence
f transient or permanent focal neurologic deficit that was con-
rmed as a new deficit by means of computed tomography. Re-
piratory insufficiency was defined as prolonged intubation for more
han 48 hours because of inadequate status of gas exchange. Criteria
or extubation included adequate response to commands, respiratory
ate greater than 12 breaths/min, end-tidal carbon dioxide tension less
han 50 mm Hg, and an oxygen saturation by pulse oximetry greater
han 95% at an inspired oxygen fraction of 0.3.
tatistical Analysis
esults are expressed as mean  SD. Statistical analyses were
erformed with the Student t-test for continuous variables or with
2 tests (Fisher exact tests if n  5) for categorical variables.
In view of the marked and significant differences in patient
haracteristics between the groups, patient matching seemed nec-
ssary to evaluate the genuine effects of temperature on mortality
nd morbidity. To compensate for the differences in this retrospec-
uary 2007
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Pive, nonrandomized study, we used a propensity score matching
nalysis. For this purpose, logistic regression was used to develop
propensity score.11,12 The propensity score included age, sex,
ody mass index, reoperation, emergency operation, Marfan syn-
rome, previous neurologic events, smoking history, hypertension,
yperlipidemia, chronic obstructive pulmonary disease, diabetes
ABLE 1. Patient characteristics
Entire study
Overall
Deep
LBCA
atients (No.) 377 125
ge (y, mean  SD) 61.8  11.8 60.9  13.1
ale (No.) 262 (69.5%) 81 (64.8%)
ody mass index (kg/m2, mean  SD) 26.5  4.1 25.6  3.8
eoperative case (No.) 72 (19.1%) 24 (19.2%)
mergency (No.) 141 (37.4%) 55 (44.0%)
ype A dissection (No.) 126 (33.4%) 50 (40.0%)
arfan syndrome (No.) 7 (1.9%) 6 (4.8%)
istory of neurologic event (No.)
Transient 11 (2.9%) 6 (4.8%)
Persistent 25 (6.6%) 7 (5.6%)
moking history (No.) 133 (35.3%) 56 (44.8%)
ypertension (No.) 291 (77.2%) 99 (79.2%)
yperlipidemia (cholesterol 200
mg/dL, No.)
168 (44.6%) 55 (44.0%)
iabetes mellitus (insulin dependent,
No.)
4 (1.1%) 1 (0.8%)
hronic obstructive pulmonary
disease (No.)
79 (21.0%) 28 (22.4%)
eripheral arterial disease (No.) 12 (3.2%) 4 (3.2%)
oronary artery disease (No.) 113 (30.0%) 29 (23.2%)
hronic renal insufficiency (No.) 40 (10.6%) 11 (8.8%)
CBA, Lower body circulatory arrest.
igure 1. Distribution of patients by hypothermic circulatory ar-
oest time. LBCA, Lower body circulatory arrest.
The Journal of Thoracicellitus (insulin dependent), peripheral vascular disease, coronary
rtery disease, renal insufficiency (creatinine 2.0 mg/dL), total
rch replacement, concomitant operations (aortic valve root oper-
tion, coronary artery bypass grafting, mitral valve operation),
uration of aortic crossclamping, and duration of LBCA. From
hese covariables, a propensity score was calculated for each
atient. Finally, each patient in the deep LBCA group was matched
ith a patient in the moderate LBCA group with the closest
ropensity score. The maximum difference in propensity score for
match was less than 0.015. By using this novel method, compa-
able patient groups (92 patients from each group) were identified
or final analysis (Table 1). Logistic regression was also used for
he analysis of risk factors for postoperative mortality and mor-
idity and the effects of temperature on postoperative mortality
nd morbidity. All statistical analyses were performed with SPSS
0.0 software (SPSS Inc, Chicago, Ill).
esults
nalysis of the Entire Patient Population
ate of total arch replacement was significantly higher in the
eep LBCA group than in the moderate LBCA group (31% vs
9%, P  .008). This may be related to longer durations of
BCA (34.1  24.4 minutes in deep LBCA group vs 23.5 
5.8 minutes in moderate LBCA group, P  .001), SCP
25.8  18.1 vs 18.8  14.2 minutes, P  .001), CPB
193.3  77.9 vs 175.7  67.1 minutes, P  .025), and
le Propensity-matched pairs
derate
BCA P value Overall
Deep
LBCA
Moderate
LBCA P value
252 184 92 92
 11.1 .31 62.1  11.2 62.2  12.0 62.0  10.0 .88
(71.8%) .16 123 (66.8%) 60 (65.2%) 63 (68.4%) .63
 4.2 .002 26.3  3.6 26.2  3.8 26.4  3.4 .79
(19.0%) .97 33 (17.9%) 17 (18.4%) 16 (17.3%) .84
(34.1%) .62 71 (38.6%) 37 (40.2%) 34 (36.9%) .65
(30.1%) .57 66 (35.9%) 34 (36.9%) 32 (34.7%) .75
(0.3%) .003 1 (0.5%) 0 (0%) 1 (1.08%) .31
(1.9%) .12 4 (2.2%) 1 (1.08%) 3 (3.2%) .31
(7.1%) .57 14 (7.6%) 7 (7.6%) 7 (7.6%) .99
(30.5%) .006 82 (44.6%) 42 (45.6%) 40 (43.4%) .76
(76.1%) .51 148 (80.4%) 74 (80.4%) 74 (80.4%) .99
(44.8%) .87 84 (45.7%) 41 (44.5%) 43 (46.7%) .76
(1.1%) .72 2 (1.1%) 1 (2.3%) 1 (2.3%) .99
(20.2%) .62 43 (23.4%) 22 (23.9%) 21 (22.8%) .86
(3.1%) .98 9 (4.9%) 4 (4.3%) 5 (5.4%) .73
(33.3%) .43 55 (29.9%) 25 (27.1%) 30 (32.6%) .42
(11.5%) .42 15 (8.2%) 8 (8.6%) 7 (7.6%) .78samp
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CSP023) in the deep LBCA group than in the moderate LBCA
roup. Intensive care unit stay was longer in the deep LBCA
roup (5.0  6.7 vs 3.8  5.4 days, P  .05). In-hospital
ortalities were 11.2% in the deep LBCA group and 7.9%
n the moderate LBCA group (P  .29). There was a trend
oward a higher rate of reexploration for postoperative
leeding in the deep LBCA group (20% vs 13%, P  .08);
owever, there were no differences in other complications
etween the groups (Table 2).
ropensity Score Matching Analysis
aseline characteristics of propensity-matched pairs were
lmost identical (Table 1). There were no significant differ-
nces in CPB time (184.1  69.4 in deep LBCA group vs
86.3  72.8 minutes in moderate LBCA group, P  .83)
nd operative time (289.5 94.8 vs 296.1 108.5 minutes,
ABLE 2. Perfusion data and postoperative morbidity and
Entire study samp
Overall
Deep
LBCA
M
atients (No.) 377 125
ean temperature (°C,
mean  SD)
25.3  1.8 23.2  1.2 26
otal arch replacement (No.) 87 (23.1%) 39 (31.2%) 48
uration of operation (min,
mean  SD)
287.4  100.2 304.8  112.5 279
uration of cardiopulmonary
bypass (min,
mean  SD)
181.4  71.2 193.3  77.9 175
uration of aortic
crossclamping (min, mean 
SD)
114.4  40.7 117.7  43.2 112
uration of hypothermic
circulatory arrest (min,
mean  SD)
27.0  19.6 34.1  24.4 23
uration of selective cerebral
perfusion (min, mean  SD)
21.1  15.9 25.8  18.1 18
uration of mechanical
ventilation (h, mean  SD)
70.5  157.8 88.3  206.0 61
ntensive care unit stay (d,
mean  SD)
4.2  5.9 5.0  6.7 3
n-hospital death (No.) 34 (9.0%) 14 (11.2%) 20
troke (No.) 23 (6.1%) 10 (8.0%) 13
emporary neurologic
dysfunction (No.)
60 (15.9%) 28 (22.4%) 32
eexploration for bleeding (No.) 58 (15.4%) 25 (20.0%) 33
espiratory insufficiency (No.) 41 (10.9%) 14 (11.2%) 27
racheotomy (No.) 35 (9.3%) 15 (12.0%) 20
enal failure (No.) 30 (7.9%) 13 (4.8%) 17
emporary dialysis (No.) 23 (6.1%) 9 (7.2%) 14
ermanent dialysis (No.) 7 (1.9%) 4 (3.2%) 3
araplegia (No.) 8 (2.1%) 4 (3.2%) 4
CBA, Lower body circulatory arrest. .62) between the deep and moderate LBCA groups. (
04 The Journal of Thoracic and Cardiovascular Surgery ● Febrn-hospital mortalities were 8.6% in the deep LBCA group
nd 10.8% in the moderate LBCA group (P  .62). There
as no significant difference in reexploration for postoper-
tive bleeding between the deep and moderate LBCA
roups (19.5% vs 14.1%, P  .32) and also no differences
n any other postoperative complications between the
roups (Table 2).
Time courses of the following factors were also analyzed
n the propensity-matched groups: blood urea nitrogen, cre-
tinine, and urinary output as an index of renal function;
spartate aminotransferase as an index of liver injury; cre-
tine kinase as an index of muscle injury; lactate as an index
f whole-body ischemic injury; C-reactive protein as an
ndex of inflammatory response; and ratio of arterial to inspired
xygen concentration as an index of gas exchange function
ality
Propensity-matched pairs
ate
A P value Overall
Deep
LBCA
Moderate
LBCA P value
184 92 92
0.9 .0001 24.8  1.9 23.3  1.3 26.3  0.9 .0001
0%) .008 47 (25.5%) 23 (25.0%) 24 (26.0%) .86
92.6 .023 292.8  101.6 289.5  94.8 296.1  108.5 .66
67.1 .025 185.2  70.9 184.1  69.4 186.3  72.8 .83
39.4 .24 116.6  41.8 114.6  40.7 118.6  42.9 .51
15.8 .001 28.0  18.1 27.7  16.1 28.4  19.9 .81
14.2 .001 22.4  16.9 22.3  15.2 22.6  18.4 .90
126.7 .12 74.3  183.6 82.2  218.6 66.5  141.1 .56
5.4 .05 4.4  6.4 4.6  6.6 4.1  6.3 .57
%) .29 18 (9.8%) 8 (8.6%) 10 (10.8%) .62
%) .27 12 (6.5%) 6 (6.5%) 6 (6.5%) .99
6%) .15 22 (12%) 13 (14.1%) 9 (9.7%) .36
0%) .08 31 (16.8%) 18 (19.5%) 13 (14.1%) .32
7%) .88 22 (12%) 11 (11.9%) 11 (11.9%) .99
%) .20 16 (8.7%) 9 (9.7%) 7 (7.6%) .60
%) .48 14 (7.6%) 8 (8.6%) 6 (6.5%) .58
%) .54 12 (6.5%) 6 (6.5%) 6 (6.5%) .99
%) .17 2 (1.1%) 2 (2.1%) 0 (0%) .15
%) .30 7 (3.8%) 4 (4.3%) 3 (3.2%) .70mort
le
oder
LBC
252
.3 
(19.
.2 
.7 
.5 
.5 
.8 
.7 
.8 
(7.9
(5.1
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(13.
(10.
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(5.5
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(1.5Appendix Table E1). Only the difference in C-reactive protein
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Pevel at 1 day after the operation approached (but did not reach)
tatistical significance (108.4  47.7 mg/L in deep LBCA
roup vs 95.8  44.2 mg/L in moderate LBCA group, P 
07; Figure 2).
ubanalysis 1: Patients With LBCA Longer Than
0 Minutes
s shown in Figure 1, most of the patients underwent
BCA for less than 60 minutes, and only 27 (7%) patients
nderwent LBCA for longer than 60 minutes. Prolonged
BCA can theoretically lead to higher mortality, and pro-
onged LBCA at higher temperature appears to be dangerous;
n additional subanalysis was therefore performed on the entire
igure 2. Time course of C-reactive protein in propensity-
atched groups. LBCA, Lower body circulatory arrest; Preop.,
reoperative.
ABLE 3. Subanalysis: Patients with hypothermic circulat
atients (No.)
ge (y, mean  SD)
ale (No.)
ype A dissection (No.)
ortic valve root operation (No.)
oronary artery bypass grafting (No.)
otal arch replacement (No.)
uration of operation (min, mean  SD)
uration of cardiopulmonary bypass (min, mean  SD)
uration of aortic crossclamping (min, mean  SD)
uration of hypothermic circulatory arrest (min, mean  SD)
uration of selective cerebral perfusion (min, mean  SD)
eexploration for bleeding (No.)
uration of mechanical ventilation (h, mean  SD)
ntensive care unit stay (d, mean  SD)
n-hospital death (No.)
troke (No.)
emporary neurologic dysfunction (No.)
espiratory insufficiency (No.)
ostoperative use of dialysis (No.)
araplegia (No.)CBA, Lower body circulatory arrest.
The Journal of Thoracicatient population to examine any effects of the temperature at
he initiation of LBCA on the outcomes of patients with LBCA
uration longer than 60 minutes. Mortalities were 19% (5/27
atients) among patients who underwent LBCA for longer than
0 minutes and 8% (29/350 patients) among those with LBCA
ess than 60 minutes (P  .08). Among the 27 patients with
BCA longer than 60 minutes, mortalities were 12.5% in
he deep LBCA group and 27.3% in the moderate LBCA
roup (P  .33). There was a trend toward higher occur-
ence of paraplegia in the moderate LBCA group (0% in
eep LBCA group and 18% in moderate LBCA group, P 
08). There were no significant differences in any other
ostoperative complications (Table 3).
ubanalysis 2: Acute Aortic Dissection Type A
mergency operation for acute aortic dissection type A was a
trong risk factor for mortality. In the entire study cohort, the
ortalities were 5.6% among patients with nonacute dissection
nd 15.9% among those with acute dissection (P  .001). To
xamine the effects of the temperature at LBCA on out-
omes in this high-risk cohort, a subanalysis was performed
n the entire patient population. There were no differences
n perfusion data (CPB, aortic crossclamping, HCA, and
CP times). Mortalities were 18% (9/50 patients) in the
eep LBCA group and 14.5% (11/76 patients) in the mod-
rate LBCA group (P  .59). There were no significant
ifferences in rates of any postoperative complications be-
ween the groups (Table 4).
rrest longer than 60 minutes
Overall Deep LBCA Moderate LBCA P value
27 16 11
.5  12.2 53.7  12.3 60.6  11.4 .15
2 (81.5%) 12 (75.0%) 10 (90.9%) .29
2 (44.4%) 4 (25.0%) 8 (72.7%) .014
0 (37.0%) 4 (25.0%) 6 (54.5%) .12
4 (14.8%) 2 (12.5%) 2 (18.2%) .68
3 (85.2%) 12 (75.0%) 11 (100%) .07
.7  136.1 390.8  166.2 326.8  63.6 .26
.9  94.2 266.6  112.2 210.8  46.5 .13
.5  60.5 127.2  68.7 140.2  48.3 .59
.6  20.2 85.3  22.5 73.8  14.7 .15
.1  13.2 61.8  11.9 64.9  15.2 .56
9 (33.3%) 7 (43.8%) 2 (18.2%) .16
.0  270.4 155.1  223.4 226.2  334.6 .51
.2  11.5 7.8  9.0 11.2  14.6 .44
5 (18.5%) 2 (12.5%) 3 (27.3%) .33
6 (22.2%) 3 (18.8%) 3 (27.3%) .60
6 (22.2%) 5 (31.3%) 1 (9.1%) .17
6 (22.2%) 4 (25.0%) 2 (18.2%) .68
4 (14.8%) 2 (12.5%) 2 (18.2%) .68
2 (7.4%) 0 (0%) 2 (18.2%) .08ory a
56
2
1
1
2
364
243
132
80
63
184
9and Cardiovascular Surgery ● Volume 133, Number 2 505
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CSPisk Factors for Postoperative Mortality
nd Morbidity
o detect risk factors for postoperative mortality and mor-
idity in our study cohort, multivariate analyses were per-
ormed (Table 5). In these analyses, CPB and LBCA times
ABLE 4. Subanalysis: Patients with acute aortic dissecti
atients (No.)
ge (y, mean  SD)
ale (No.)
ortic valve-root operation (No.)
oronary artery bypass grafting (No.)
otal arch replacement (No.)
uration of operation (min, mean  SD)
uration of cardiopulmonary bypass (min, mean  SD)
uration of aortic crossclamping (min, mean  SD)
uration of hypothermic circulatory arrest (min, mean  SD)
uration of selective cerebral perfusion (min, mean  SD)
eexploration for bleeding (No.)
uration of mechanical ventilation (h, mean  SD)
ntensive care unit stay (d, mean  SD)
n-hospital death (No.)
troke (No.)
emporary neurologic dysfunction (No.)
espiratory insufficiency (No.)
ostoperative use of dialysis (No.)
araplegia (No.)
CBA, Lower body circulatory arrest.
ABLE 5. Risk factors for postoperative mortality and mor
Entire study sample
ortality CPB time (P  .0001), OR 1.011, 95%
emporary neurologic
dysfunction
Age (P  .003), OR 1.046, 95% CI 1.0
Total arch replacement (P  .008),
CI 1.422-10.339
LBCA time (P  .005), OR 1.029 95%
troke CPB time (P  .006), OR 1.006, 95%
LBCA time (P  .008), OR 1.030, 95%
eexploration for bleeding CPB time (P  .002), OR 1.006, 95%
espiratory failure Reoperative case (P  .005), OR 3.6
1.484-8.910
CPB time (P  .002), OR 1.007 95%
Age (P  .002), OR 1.063 95% CI 1.0
ostoperative dialysis Age (P  .002), OR 1.074 95% CI 1.0
CPB time (P  .005), OR 1.007 95%
araplegia NonePB, Cardiopulmonary bypass; OR, odds ratio; CI, confidence interval; LBCA, lo
06 The Journal of Thoracic and Cardiovascular Surgery ● Febrere treated as a continuous variable, and the odds ratio
eflected per degree risk. The temperature was also treated
s a continuous variable, and the odds ratio therefore re-
ected per degree risk. Prolonged CPB was strongly asso-
iated with most postoperative adverse events, and the tem-
pe A
Overall Deep LBCA Moderate LBCA P
126 50 76
0.6  12.7 59.0  15.3 61.7  10.8 .24
92 (73.0%) 36 (72.0%) 56 (73.6%) .83
9.0 (62.7%) 30 (60.0%) 49 (64.4%) .61
13 (10.3%) 2 (4.0%) 11 (14.5%) .06
34 (27.0%) 12 (24.0%) 22 (28.9%) .54
9.2  102.7 286.6  121.9 291.0  88.7 .81
4.6  76.5 194.1  89.1 194.9  67.7 .95
5.9  44.5 128.7  47.5 124.1  42.7 .57
3.6  16.0 33.5  15.9 33.8  16.3 .91
7.5  14.8 26.7  14.3 27.9  15.2 .65
28 (22.2%) 13 (26.0%) 15 (19.7%) .41
1.3  167.8 79.0  131.1 116.1  187.4 .22
5.7  6.9 5.2  5.5 6.0  7.7 .52
20 (15.9%) 9 (18.0%) 11 (14.5%) .59
10 (7.9%) 5 (10.0%) 5 (6.6%) .49
29 (23.0%) 15 (30.0%) 14 (18.4%) .13
20 (15.9%) 6 (6.0%) 14 (22.3%) .34
19 (15.1%) 7 (14.0%) 12 (15.8%) .78
6 (4.8%) 3 (6.0%) 3 (3.9%) .6
y analyzed with multivariate logistic regression
Propensity-matched sample
.007-1.016 CPB time (P  .001), OR 1.011 95% CI 1.004-1.018
Reoperative case (P  .014), OR 6.666 95% CI
1.457-30.439
.077
834 95%
None
.009-1.049
002-1.013 CPB time (P  .006), OR 1.011 95% CI 1.003-1.019
.008-1.053 LBCA time (P  .028), OR 1.056 95% CI 1.006-1.109
002-1.010 CPB time (P  .004), OR 1.009 95% CI 1.003-1.015
Reoperative case (P  .014), OR 3.902 95% CI
1.324-11.497
Temperature (P  .046), OR 0.796 95% CI 0.636-
0.996
% CI Reoperative case (P  .037), OR 3.896 95% CI
1.086-13.977
02-1.011 CPB time (P  .0001), OR 1.011 95% CI 1.005-1.017
104
124 Age (P  .024), OR 1.089 95% CI 1.011-1.174
02-1.012 CPB time (P  .004), OR 1.012 95% CI 1.004-1.021)
BMI (P  .019), OR 1.315 95% CI 1.045-1.654on ty
6
7
28
19
12
3
2
10bidit
CI 1
16-1
OR 3.
CI 1
CI 1.
CI 1
CI 1.
37 95
CI 1.0
24-1.
27-1.
CI 1.0wer body circulatory arrest; BMI, body mass index.
uary 2007
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CS
Perature was only statistically significantly associated with
eexploration for bleeding. Paraplegia, an uncommon yet
ritical complication in arch replacement, was seen in 8
atients in our study cohort. In these analyses, no risk
actors could be identified in the entire study cohort, and
ody mass index was the only risk factor for postoperative
araplegia in the propensity-matched cohort.
ssociations Between Postoperative Complications
nd Temperature
o examine associations between postoperative compli-
ations and the temperature at the initiation of LBCA,
nivariate and multivariate analyses were performed (Ta-
le 6). In these analyses, the temperature was treated as
continuous variable and the odds ratio therefore re-
ected per degree risk. Reexploration for bleeding was
he only factor significantly associated with temperature.
n the entire study sample, the mean temperatures at the
nitiation of LBCA were 24.9°C  2.2°C among patients
ho underwent reexploration and 25.4°C  1.7°C among
hose without it (P .046), but this difference did not reach
tatistical significance in the multivariate analysis (P .39).
n the propensity-matched cohort, the mean temperatures at
he initiation of LBCA were 24.1°C  2.2°C among pa-
ients who underwent reexploration and 24.9°C  1.8°C
mong those without it (P  .025); this difference also
eached statistical significance in the multivariate analysis
P  .046, odds ratio, 0.796). For the occurrence of para-
legia, multivariate analysis could not be performed be-
ABLE 6. Association between postoperative complication
ariable
Entire study sample
Status
Mean
temp (°C)
Uni
P
value
Multi
P
value OR
ortality Dead (n 34) 24.9 2.1 .13 .91 0.98 0.
Survived
(n  343)
25.4 1.7
ND Yes (n 52) 25.1 1.7 .24 .76 0.97 0.
No (n  325) 25.4 1.8
troke Yes (n 23) 24.9 2.1 .37 .82 1.04 0.
No (n  354) 25.3 1.8
eexploration
for bleeding
Yes (n 58) 24.9 2.2 .05 .39 0.92 0.
No (n  319) 25.4 1.7
espiratory
failure
Yes (n 40) 25.1 1.8 .40 .45 1.10 0.
No (n  337) 25.3 1.8
ostoperative
dialysis
Yes (n 28) 24.8 1.8 .12 .17 0.80 0.
No (n  349) 25.4 1.8
araplegia Yes (n 8) 24.2 2.2 .08 NA NA
No (n  369) 25.3 1.8
emp, Temperature; Uni, univariate; Multi, multivariate; OR, Odds ratio; CI,ause of the low number of events. a
The Journal of Thoraciciscussion
n this study, there were no significant differences in mor-
ality or morbidity between deep and moderate LBCA in
ither the entire study cohort or the propensity-matched
ohort. There was a trend toward lower postoperative in-
ammatory response in patients with moderate LBCA,
owever, which fell short of reaching statistical signifi-
ance, and deep LBCA was strongly associated with reex-
loration for bleeding.
At the beginning of this study, we found the differences
n the distribution of patient baseline data to be too great for
proper analysis. Patients with deep LBCA had lower body
ass index, greater incidence of Marfan syndrome, and
ore smoking history. Moreover, they underwent fewer
oncomitant procedures (Appendix Table E2), more total
rch replacement, and longer duration of LBCA. To gener-
te a reasonable control group, propensity matching was
erformed for this study.12,13 Because LBCA and aortic
rossclamping times are dependent on the surgical proce-
ure and independent of the temperature at the initiation of
BCA, both factors were included in the matching process.
perative and CPB times were not included in this process,
ecause we considered those factors to be dependent on
BCA, aortic crossclamping, cooling, rewarming, and he-
ostasis times.
Against our speculation, there were no differences in CPB
nd operative times between the groups in the propensity-
atched cohort. Generally, it is considered that deep hypother-
ia is associated with prolonged CPB,7 and Harrington and
d temperature
Propensity-matched sample
CI Status
Mean
temp (°C)
Uni
P
value
Multi
P
value OR 95% CI
.292 Dead (n 18) 24.8 2.0 .94 .587 1.090 0.799-1.485
Survived
(n  166)
24.9 1.9
.184 Yes (n 22) 24.9 1.6 .66 .441 1.108 0.854-0.147
No (n 162) 24.8 1.9
.479 Yes (n 12) 24.7 2.2 .86 .982 1.004 0.691-1.460
No (n 172) 24.8 1.9
.117 Yes (n 31) 24.1 2.2 .03 .046 0.796 0.636-0.996
No (n 153) 24.9 1.8
.430 Yes (n 22) 24.6 2.1 .59 .839 1.029 0.779-1.360
No (n 162) 24.8 1.8
.103 Yes (n 14) 24.3 1.7 .30 .298 0.841 0.607-1.165
No (n 170) 24.8 1.9
Yes (n 7) 23.9 2.2 .20 NA NA NA
No (n 177) 24.8 2.2
ence interval; TND, temporary neurologic dysfunction; NA, not available.s an
95%
752-1
179-1
733-1
754-1
852-1
581-1
NAssociates14 reported that mean CPB times were 191  53
and Cardiovascular Surgery ● Volume 133, Number 2 507
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CSPinutes in a deep hypothermic CPB group and 131  48
inutes in a moderate hypothermic CPB group (P  .0001),
ith their deep hypothermic CPB group undergoing HCA for
1 14 minutes. Theoretically, longer cooling and rewarming
imes are required for deep HCA; in our series, however, 75%
f patients underwent concomitant procedures during the cool-
ng and rewarming phases. This may account for the lack of
ifferences in CPB and operative times between the two
roups.
As we speculated, there were no differences in neuro-
ogic adverse event between the groups in any analysis. SCP
rotocol was identical in the two groups, and hypothermia
as only needed as a brain protection during the period
rom the termination of CPB to the initiation of SCP and
rom the termination of SCP to the resumption of CPB. In
ur series, the difference between HCA and SCP times was
pproximately 6 minutes. Our data suggest that the differ-
nce in temperature at LBCA does not affect the quality of
erebral protection during this period.
Although the spinal cord consists of neural cells such as
re present in the cerebrum and is most likely sensitive to
schemic damage in a similar manner as in the brain, the
ccurrences of paraplegia were similar in the two groups.
his outcome may have been due to our institutional per-
usion protocol. We performed SCP with cold blood at
5°C, and it was observed in general that the nasopharyn-
eal temperature would continue to fall during the LBCA
eriod, commonly dropping to 20°C, although the temper-
ture of the bladder would remain at the temperature at the
nitiation of LBCA. The mechanism of this phenomenon is
nclear, but perhaps it was caused by the collateral blood
ow through the vertebral artery and the returned cool blood
rom the head to the right atrium. It can be speculated that
his cooling phenomenon acted protectively for the spinal
ord and therefore resulted in a relatively low incidence of
araplegia among patients with moderate LBCA.
There were also no differences in the biologic parameters
f any other organs. Similar to our results, Harrington and
ssociates14 concluded that hypothermic CPB is not a risk
actor for renal or early pulmonary dysfunction. Generally,
isceral organs, including the lungs, can tolerate ischemic
amage better than can the brain or the heart. Our results
uggest that visceral organs can be well protected by mod-
rate LBCA.
In this series, only the difference in C-reactive protein
evel 1 day after the operation approached statistical
ignificance (P  .08). The actual adverse effects of deep
ypothermia on inflammatory response have not been
ade clear, but our results suggest that deep LBCA may
ctivate inflammatory response, as others have already
peculated.7,15 This issue, however, appears to be difficult to
rove in a clinical setting. In this series there were no m
08 The Journal of Thoracic and Cardiovascular Surgery ● Febrifferences in any clinical outcomes except reexploration
or bleeding.
It is well known that coagulopathy is induced by hypo-
hermia16,17 but it has been difficult to prove this association
n a clinical setting, especially with regard to HCA, as seen
n the report by Harrington and associates14 in which pro-
ound hypothermia was not associated with increased post-
perative hemorrhage in their comparative study of deep
CA.14 In our study, reexploration for bleeding was the
nly factor significantly associated with temperature. This
esult suggests that the use of deep LBCA can possibly
ause postoperative bleeding.
Generally, acute aortic dissection type A is associated
ith high mortality, and this was also the case in our series.
ven in this high-risk cohort, however, there were no dif-
erences in clinical outcome between the two groups. Our
esults demonstrate that moderate LBCA is a safe strategy
or the treatment of acute aortic dissection type A.
Among the patients who underwent HCA for longer than
0 minutes, 2 patients (1 with acute aortic dissection type A
nd 1 without it) who underwent moderate LBCA had
araplegia occur, whereas none of those who underwent
eep LBCA did (P  .08). There were neither significant
ifferences nor any trends toward significance in any other
ostoperative adverse effects. In our entire study cohort,
nly 7% of the patients (n  27) underwent LBCA for
onger than 60 minutes, as shown in Figure 1, and this
atient volume was too small to conclude anything from a
ubanalysis. On the other hand, LBCA time was 50.2 
0.7 minutes among patients who underwent total arch
eplacement and 20.4  13.1 minutes among patients who
nderwent hemiarch replacement (P  .0001), and the
ercentages of paraplegia were 4.7% (4/85 patients) and
.4% (4/292 patients), respectively (P  .064). In our
nstitution, arch vessels are commonly reconstructed as an
sland, and this might explain why most of the cases were
ompleted with less than 60 minutes of LBCA. Here it
hould be strongly emphasized that the results of this study
o not support the suggestion that moderate LBCA has no
ime limit, and this method should not be used for patients
ho require complex total arch replacement with individual
rch vessel reconstruction.
Unfortunately, we could not find the optimal temperature
or LBCA and consider this a study limitation. The LBCA
emperature ranged mainly from 25°C to 28°C, and the
ptimal temperature could not be identified with this con-
entration in distribution in our preliminary pilot study. The
emperature of 25°C to 28°C is quite higher than reported in
ther institutions,8-10 however, and we believe that it is
eaningful to analyze and discuss the safety of LBCA in
his temperature range.
In conclusion, there were no significant differences inortality or morbidity between deep and moderate LBCA
uary 2007
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Kamiya et al Cardiopulmonary Support and Physiologyn either the entire study cohort or the propensity-matched
ohort. There was a trend toward lower postoperative in-
ammatory response in patients with moderate LBCA,
owever, and deep LBCA was strongly associated with
eexploration for bleeding. Our results suggest that moder-
te LBCA can be safely performed for aortic arch repair for
0 minutes or less. It remains unclear whether it is safe
eyond 60 minutes.
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CSPppendix TABLE E1.
erioperative parameters from propensity-matched cohort
Deep LBCA Moderate LBCA P value
lood urea nitrogen (mmol/L)
Preoperative 6.7 2.8 6.9  3.7 .79
0 h after operation 6.7 3.0 6.6  2.6 .93
6 h after operation 7.5 3.1 7.3  2.9 .77
1 d after operation 9.2 3.9 8.9  4.1 .69
5 d after operation 9.7 6.1 10.4 7.3 .55
reatinine (mol/L)
Preoperative 90.9 49.2 97.9 52.7 .36
0 h after operation 91.0 49.2 89.9 27.4 .85
6 h after operation 103.3 53.5 98.7 40.3 .52
1 d after operation 119.7 78.6 117.5 74.8 .84
5 d after operation 103.5 72.2 105.8 81.0 .85
spartate aminotransferase (U/L)
Preoperative 29.3 97.6 37.2 81.3 .57
0 h after operation 53.5 79.5 63.1 90.3 .55
6 h after operation 79.9 125.9 94.7 110.5 .46
1 d after operation 116.1 250.4 103.9 162.4 .71
5 d after operation 91.0 49.2 91.0 49.2 .50
reatine kinase (U/L)
Preoperative 66.6 61.8 101.0 293.8 .30
0 h after operation 338.6 376.7 302.4 301.1 .48
6 h after operation 538.2 643.8 735.3 2062.2 .39
1 d after operation 771.2 1087.2 1215.2 3567.1 .26
5 d after operation 284.8 840.9 280.2 708.7 .97
actate (mmol/L)
Preoperative 2.8 1.2 2.3  1.7 .60
0 h after operation 6.4 4.1 5.9  3.0 .63
6 h after operation 5.5 3.6 5.5  3.8 .97
1 d after operation 3.2 2.9 3.2  3.6 .94
5 d after operation 1.5 1.0 1.4.  0.72 .93
-reactive protein (mg/L)
Preoperative 26.5 40.9 33.2 49.8 .45
0 h after operation 14.5 17.5 19.0 21.7 .31
6 h after operation 39.5 27.4 36.7 36.8 .63
1 d after operation 108.4 47.7 95.8 44.2 .07
5 d after operation 134.2 71.1 123.8 47.6 .31
rterial oxygen fraction/inspired oxygen fraction
Preoperative 377.9 110.7 369.9 116.1 .65
0 h after operation 345.3 125.7 335.9 131.3 .64
6 h after operation 325.8 123.9 321.6 105.6 .81
rinary output first 24 h (mL) 2556.1 1016.3 2694.2 1351.7 .44
ll data are mean  SD. LCBA, Lower body circulatory arrest.09.e1 The Journal of Thoracic and Cardiovascular Surgery ● February 2007
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Pppendix TABLE E2.
oncomitant operations
Entire study sample Propensity-matched pairs
Overall
Deep
LBCA
Moderate
LBCA P value Overall
Deep
LBCA
Moderate
LBCA P value
oncomitant operation 280 (74.3%) 85 (68.0%) 195 (77.3%) .05 138 (75.0%) 69 (75.0%) 69 (75.0%) .99
ortic valve root operation 252 (66.8%) 76 (60.8%) 176 (69.8%) .79 122 (66.3%) 61 (66.3%) 61 (66.3%) .99
oronary artery bypass grafting 80 (21.2%) 19 (15.2%) 61 (24.2%) .44 32 (17.4%) 14 (15.2%) 18 (19.5%) .43
itral valve operation 6 (1.6%) 0 (0%) 6 (2.3%) .82 0 (0%) 0 (0%) 0 (0%)
ll data are numbers and percentages of patients. LCBA, Lower body circulatory arrest.The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 2 509.e2
